Impact and effectiveness of pentavalent rotavirus vaccine in children &lt;5 years of age in Burkina Faso. (Q47228552)

12 January 2018

title

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso. (English)

1 reference

12 January 2018

0 references

1 reference

19

Umesh D Parashar

1 reference

12 January 2018

18

Jacqueline E Tate

1 reference

12 January 2018

12

Lassana Sangaré

1 reference

12 January 2018

17

Jason M Mwenda

1 reference

12 January 2018

Negar Aliabadi

2

Negar Aliabadi

1 reference

12 January 2018

Eyal Leshem

3

Eyal Leshem

1 reference

12 January 2018

Isidore Juste O Bonkoungou

1

Isidore Juste O Bonkoungou

1 reference

12 January 2018

Désiré Nezien

5

Désiré Nezien

1 reference

12 January 2018

Isaïe Medah

9

Isaïe Medah

1 reference

12 January 2018

Joseph N M Biey

16

Joseph N Biey

1 reference

12 January 2018

author name string

Madibèlè Kam

4

1 reference

12 January 2018

Maxime K Drabo

6

1 reference

12 January 2018

Moumouni Nikiema

7

1 reference

12 January 2018

Boureima Ouedraogo

8

1 reference

12 January 2018

Souleymane Konaté

10

1 reference

12 January 2018

Rasmata Ouédraogo-Traoré

11

1 reference

12 January 2018

Ludovic Kam

13

1 reference

12 January 2018

Diarra Yé

14

1 reference

12 January 2018

Ma Ouattara

15

1 reference

12 January 2018

language of work or name

English

0 references

publication date

28 December 2017

1 reference

12 January 2018

published in

Vaccine

1 reference

12 January 2018

Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Epidemiology of rotavirus infection among young children with acute diarrhoea in Burkina Faso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Rotavirus in diarrheal children in rural Burkina Faso: high prevalence of genotype G6P[6].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Rotavirus vaccines in routine use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Rotavirus vaccines: current status and future considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Commentary: Reanalysis of the results of two rotavirus vaccine trials: an appraisal of the reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Epidemiologic and genotypic characteristics of rotavirus strains detected in children less than 5 years of age with gastroenteritis treated at 3 pediatric hospitals in Zimbabwe during 2008-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Surveillance for rotavirus gastroenteritis in children less than 5 years of age in Togo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Duration of protection of pentavalent rotavirus vaccination in Nicaragua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.12.056

10.1016/J.VACCINE.2017.12.056

7 January 2021

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

29290478

1 reference

12 January 2018